TY - JOUR
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adulthood (18 yrs & older)
KW - article
KW - buprenorphine
KW - Channel Blockers
KW - Detoxification
KW - Drug Addiction
KW - Empirical Study
KW - Female
KW - gabapentin
KW - Human
KW - Humans
KW - Male
KW - Middle Age (40-64 yrs)
KW - Objective Opiate Withdrawal Scale
KW - Opiate Withdrawal Symptoms Checklist
KW - Opiates
KW - opioid withdrawal
KW - Outpatient
KW - Quantitative Study
KW - Side Effects (Drug)
KW - Thirties (30-39 yrs)
KW - Treatment Effectiveness Evaluation
KW - Treatment Outcome/Clinical Trial
KW - US
KW - Young Adulthood (18-29 yrs)
AU - Nichole C. Sanders
AU - Michael J. Mancino
AU - Brooks Gentry
AU - Benjamin Guise
AU - Warren K. Bickel
AU - Jeff Thostenson
AU - Alison H. Oliveto
A1 - 
BT - Experimental and clinical psychopharmacology
C5 - Opioids & Substance Use
CP - 4
IS - 4
JF - Experimental and clinical psychopharmacology
PB - American Psychological Association
PY - 2013
SN - 1064-1297, 1064-1297
SP - 294
EP - 302
EP - 
T1 - Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.
T2 - Experimental and clinical psychopharmacology
TI - Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/1400135870?accountid=28100
VL - 21
VO - 1064-1297, 1064-1297
Y1 - 2013
ER -